Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Evogene Ltd. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 43 | 38 | −5 |
| Shares | 6.02M | 2.45M | −3.58M (−59.4%) |
| Value | $10.0M | $3.18M | −$6.84M (−68.3%) |
New holders (2)
Institutions that held Evogene Ltd. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 36,576 | $48.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 19,400 | $25.0K | 0.00% |
Sold out (7)
Institutions that held Evogene Ltd. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| ARK Investment Management LLCSuperinvestorARK Invest | 3,611,842 | $6.02M |
| Credit Suisse AG | 57,283 | $94.0K |
| Goldman Sachs Group Inc | 29,114 | $48.0K |
| Walleye Trading LLC | 13,840 | $23.0K |
| HRT Financial LP | 13,446 | $22.0K |
| Snowden Capital Advisors LLC | 200 | $0 |
| Edge Wealth Management LLC | 50 | – |